{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:11:03Z","timestamp":1779149463962,"version":"3.51.4"},"reference-count":50,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["308362"],"award-info":[{"award-number":["308362"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Primary hyperparathyroidism (PHPT) is a systemic endocrine disorder characterized by elevated PTH levels and hypercalcemia. Gene-specific epigenetic modifications like histone methylation play a pivotal role in PHPT by altering expression of parathyroid-specific genes. However, global histone modifications in parathyroid tumors and their implications for tumor behavior remain underexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Experimental Design<\/jats:title>\n                    <jats:p>We performed comparative histone modification profiling in blood and tissue samples from sporadic parathyroid adenomas (PA; n = 30), atypical parathyroid tumors (APT; n = 05), and parathyroid carcinomas (PC; n = 05) along with controls using histone H3 multiplex immunoassay. Significantly dysregulated modifications were validated by Western blotting (WB), and expression data was correlated with clinicopathological features. We performed pathway enrichment analysis to elucidate molecular pathways potentially linked to histone H3 modifications in parathyroid tumorigenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We observed dynamic alterations in histone H3 modifications of lysine (K) residues across parathyroid tumor phenotypes in blood and tissue samples. A reduction in H3K4 and H3K36 trimethylation (&amp;lt;60%) and an increase in H3K27 trimethylation and H3K9 monomethylation (&amp;gt;130%) compared to controls was observed. WB confirmed lower H3K4me3 (0.5 \u00b1 0.4 vs 4.4 \u00b1 0.7, P = .02; 0.4 \u00b1 0.2 vs 4.4 \u00b1 0.7, P = .004) and H3K36me3 (0.4 \u00b1 0.2 vs 1.0 \u00b1 0.3, P = .03; 0.2 \u00b1 0.1 vs 1.0 \u00b1 0.3, P = .02) in APT and PC than controls and higher H3K27me3 expression in PA (2.9 \u00b1 1.2 vs 1.1 \u00b1 0.21, P = .04), APT (4.2 \u00b1 2.9 vs 1.1 \u00b1 0.21, P = .007), and PC (6.9 \u00b1 3.1 vs 1.1 \u00b1 0.21, P = .0002) relative to controls. Pathway enrichment analysis identified molecular pathways, including calcium signaling, Wnt, and Hippo signaling, associated with histone H3 modifications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Increased expression of repressive H3K27me3 in blood and tissue samples, while decreased H3K4me3 and H3K36me3, suggest a shift toward transcriptional repression. Identifying their functional mechanisms may facilitate the discovery of novel insights for therapeutic targeting in parathyroid tumors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf668","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T12:54:46Z","timestamp":1765630486000},"page":"1680-1691","source":"Crossref","is-referenced-by-count":0,"title":["Aberrant Histone Methylation Profile in Patients with Sporadic Primary Hyperparathyroidism"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4057-891X","authenticated-orcid":false,"given":"Poonam","family":"Kumari","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Post Graduate Institute of Medical Education and Research , Chandigarh 160012 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0410-8778","authenticated-orcid":false,"given":"Sanjay Kumar","family":"Bhadada","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Post Graduate Institute of Medical Education and Research , Chandigarh 160012 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashutosh Kumar","family":"Arya","sequence":"additional","affiliation":[{"name":"Department of Endocrinology & Metabolism, All India Institute of Medical Sciences , New Delhi 110029 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0284-4517","authenticated-orcid":false,"given":"Jyotdeep","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Postgraduate Institute of Medical Education and Research , Chandigarh 160012 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6289-4749","authenticated-orcid":false,"given":"Naresh","family":"Sachdeva","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Post Graduate Institute of Medical Education and Research , Chandigarh 160012 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7006-5147","authenticated-orcid":false,"given":"Uma Nahar","family":"Saikia","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Postgraduate Institute of Medical Education and Research , Chandigarh 160012 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0353-3652","authenticated-orcid":false,"given":"Divya","family":"Dahiya","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Postgraduate Institute of Medical Education and Research , Chandigarh 160012 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anoop","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Postgraduate Institute of Medical Education and Research , Chandigarh 160012 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chirag","family":"Kharbanda","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Post Graduate Institute of Medical Education and Research , Chandigarh 160012 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2200-1800","authenticated-orcid":false,"given":"Sudhaker D","family":"Rao","sequence":"additional","affiliation":[{"name":"Bone and Mineral Laboratory, Henry Ford Hospital , Detroit, MI 48202 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"issue":"1","key":"2026051819573223100_dgaf668-B1","doi-asserted-by":"crossref","first-page":"16033","DOI":"10.1038\/nrdp.2016.33","article-title":"Primary hyperparathyroidism","volume":"2","author":"Bilezikian","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"2026051819573223100_dgaf668-B2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00774-017-0833-8","article-title":"Primary hyperparathyroidism: insights from the Indian PHPT registry","volume":"36","author":"Bhadada","year":"2018","journal-title":"J Bone Miner Metab"},{"key":"2026051819573223100_dgaf668-B3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s40618-024-02464-6","article-title":"Prevalence, risk factors and effect of curative parathyroidectomy on nephrocalcinosis in Asian-Indian patients with symptomatic primary hyperparathyroidism","volume":"48","author":"Kumari","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2026051819573223100_dgaf668-B4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eprac.2021.09.012","article-title":"Comparison of profile of primary hyperparathyroidism with and without type 2 diabetes mellitus: retrospective analysis from the Indian primary hyperparathyroidism registry","volume":"28","author":"Kumari","year":"2022","journal-title":"Endocr Pract"},{"issue":"2","key":"2026051819573223100_dgaf668-B5","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-18-0304","article-title":"Molecular genetic insights into sporadic primary hyperparathyroidism","volume":"26","author":"Brewer","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"2026051819573223100_dgaf668-B6","doi-asserted-by":"crossref","first-page":"101985","DOI":"10.1016\/j.beem.2025.101985","article-title":"Molecular basis of symptomatic sporadic primary hyperparathyroidism: new frontiers in pathogenesis","volume":"39","author":"Arya","year":"2025","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"2026051819573223100_dgaf668-B7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12022-021-09686-x","article-title":"Analyzing genetic differences between sporadic primary and secondary\/tertiary hyperparathyroidism by targeted next-generation panel sequencing","volume":"32","author":"Hong","year":"2021","journal-title":"Endocr Pathol"},{"key":"2026051819573223100_dgaf668-B8","doi-asserted-by":"crossref","first-page":"631680","DOI":"10.3389\/fendo.2021.631680","article-title":"Integrated whole-exome and transcriptome sequencing of sporadic parathyroid adenoma","volume":"12","author":"Hu","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2026051819573223100_dgaf668-B9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.4161\/epi.24823","article-title":"Global and gene-specific promoter methylation analysis in primary hyperparathyroidism","volume":"8","author":"Sulaiman","year":"2013","journal-title":"Epigenetics"},{"issue":"10","key":"2026051819573223100_dgaf668-B10","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.3390\/ijms23105378","article-title":"Histone modification on parathyroid tumors: a review of epigenetics","volume":"23","author":"de Freitas LC","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2026051819573223100_dgaf668-B11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s12020-015-0555-4","article-title":"Epigenetic alterations in human parathyroid tumors","volume":"49","author":"Verdelli","year":"2015","journal-title":"Endocrine"},{"issue":"5","key":"2026051819573223100_dgaf668-B12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrg3173","article-title":"Histone methylation: a dynamic mark in health, disease and inheritance","volume":"13","author":"Greer","year":"2012","journal-title":"Nat Rev Genet"},{"issue":"4","key":"2026051819573223100_dgaf668-B13","first-page":"277","article-title":"The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy","volume":"2","author":"Yang","year":"2022","journal-title":"J Natl Cancer Cent"},{"issue":"6","key":"2026051819573223100_dgaf668-B14","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.humpath.2011.07.009","article-title":"Global histone modification of histone H3 in colorectal cancer and its precursor lesions","volume":"43","author":"Nakazawa","year":"2012","journal-title":"Hum Pathol"},{"issue":"2","key":"2026051819573223100_dgaf668-B15","doi-asserted-by":"crossref","first-page":"e783","DOI":"10.1210\/clinem\/dgab626","article-title":"Aberrant epigenetic alteration of PAX1 expression contributes to parathyroid tumorigenesis","volume":"107","author":"Singh","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026051819573223100_dgaf668-B16","doi-asserted-by":"crossref","first-page":"e4084","DOI":"10.1210\/clinem\/dgab374","article-title":"GCM2 silencing in parathyroid adenoma is associated with promoter hypermethylation and gain of methylation on histone 3","volume":"106","author":"Singh","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026051819573223100_dgaf668-B17","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1210\/clinem\/dgaa419","article-title":"Reduced calcium sensing receptor (CaSR) expression is epigenetically deregulated in parathyroid adenomas","volume":"105","author":"Singh","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"20","key":"2026051819573223100_dgaf668-B18","doi-asserted-by":"crossref","first-page":"11206","DOI":"10.3390\/ijms222011206","article-title":"Parathyroid tumors: molecular signatures","volume":"22","author":"Marini","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2026051819573223100_dgaf668-B19","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.3390\/ijms22042016","article-title":"Yes-associated protein 1 is a novel calcium sensing receptor target in human parathyroid tumors","volume":"22","author":"Tavanti","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"19","key":"2026051819573223100_dgaf668-B20","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1111\/febs.15017","article-title":"The Hippo and Wnt signalling pathways: crosstalk during neoplastic progression in gastrointestinal tissue","volume":"286","author":"Li","year":"2019","journal-title":"FEBS J"},{"issue":"1","key":"2026051819573223100_dgaf668-B21","doi-asserted-by":"crossref","first-page":"101702","DOI":"10.1016\/j.ando.2025.101702","article-title":"Changes in 2022 WHO classification of parathyroid tumors","volume":"86","author":"Dupeux","year":"2025","journal-title":"Ann Endocrinol (Paris)"},{"issue":"1","key":"2026051819573223100_dgaf668-B22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12022-022-09709-1","article-title":"Overview of the 2022 WHO classification of parathyroid tumors","volume":"33","author":"Erickson","year":"2022","journal-title":"Endocr Pathol"},{"issue":"1","key":"2026051819573223100_dgaf668-B23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13148-017-0330-x","article-title":"A novel method for isolation of histones from serum and its implications in therapeutics and prognosis of solid tumours","volume":"9","author":"Reddy","year":"2017","journal-title":"Clin Epigenetics"},{"key":"2026051819573223100_dgaf668-B24","unstructured":"Kumari P, Bhadada SK, Arya AK. Extended dataset_supplementary figures S1-S4. Zenodo. 2025. doi:10.5281\/zenodo.15663991"},{"issue":"4","key":"2026051819573223100_dgaf668-B25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4331\/wjbc.v6.i4.333","article-title":"Global histone post-translational modifications and cancer: biomarkers for diagnosis, prognosis and treatment?","volume":"6","author":"Khan","year":"2015","journal-title":"World J Biol Chem"},{"issue":"1","key":"2026051819573223100_dgaf668-B26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/pros.21038","article-title":"Global levels of histone modifications predict prostate cancer recurrence","volume":"70","author":"Ellinger","year":"2010","journal-title":"Prostate"},{"issue":"2","key":"2026051819573223100_dgaf668-B27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12640-014-9508-6","article-title":"A comprehensive view of the epigenetic landscape. Part II: histone post-translational modification, nucleosome level, and chromatin regulation by ncRNAs","volume":"27","author":"Sadakierska-Chudy","year":"2015","journal-title":"Neurotox Res"},{"issue":"Suppl 1","key":"2026051819573223100_dgaf668-B28","doi-asserted-by":"crossref","first-page":"bvad114.476","DOI":"10.1210\/jendso\/bvad114.476","article-title":"SAT178 EZH2 upregulation and lysine 27 trimethylation at histone 3 is associated with severe sporadic primary hyperparathyroidism","volume":"7","author":"Kumari","year":"2023","journal-title":"J Endocr Soc"},{"issue":"5","key":"2026051819573223100_dgaf668-B29","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2353\/ajpath.2009.080874","article-title":"Global levels of histone modifications predict prognosis in different cancers","volume":"174","author":"Seligson","year":"2009","journal-title":"Am J Pathol"},{"issue":"9","key":"2026051819573223100_dgaf668-B30","doi-asserted-by":"crossref","first-page":"a025064","DOI":"10.1101\/cshperspect.a025064","article-title":"Comprehensive catalog of currently documented histone modifications","volume":"7","author":"Zhao","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2026051819573223100_dgaf668-B31","doi-asserted-by":"crossref","first-page":"1454617","DOI":"10.1155\/2019\/1454617","article-title":"Aberrant histone methylation in patients with graves\u2019 disease","volume":"2019","author":"Yan","year":"2019","journal-title":"Int J Endocrinol"},{"key":"2026051819573223100_dgaf668-B32","doi-asserted-by":"crossref","first-page":"779882","DOI":"10.3389\/fonc.2021.779882","article-title":"The role of the EZH2 and H3K27me3 expression as a predictor of clinical outcomes in salivary duct carcinoma patients: a large-series study with emphasis on the relevance to the combined androgen blockade and HER2-targeted therapy","volume":"11","author":"Saigusa","year":"2021","journal-title":"Front Oncol"},{"key":"2026051819573223100_dgaf668-B33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/14728222.2025.2482555","article-title":"Enhancer of zeste homolog 2 (EZH2) in endocrine tumors: current knowledge and future directions","volume":"29","author":"Kumari","year":"2025","journal-title":"Expert Opin Ther Targets"},{"issue":"19","key":"2026051819573223100_dgaf668-B34","doi-asserted-by":"crossref","first-page":"10782","DOI":"10.3390\/ijms251910782","article-title":"Heterogeneous transcriptional landscapes in human sporadic parathyroid gland tumors","volume":"25","author":"Verdelli","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026051819573223100_dgaf668-B35","doi-asserted-by":"crossref","first-page":"390482","DOI":"10.1155\/2013\/390482","article-title":"High expression of H3K27me3 is an independent predictor of worse outcome in patients with urothelial carcinoma of bladder treated with radical cystectomy","volume":"2013","author":"Liu","year":"2013","journal-title":"Biomed Res Int"},{"key":"2026051819573223100_dgaf668-B36","doi-asserted-by":"crossref","first-page":"152045","DOI":"10.1016\/j.anndiagpath.2022.152045","article-title":"Methylation patterns of Lys9 and Lys27 on histone H3 correlate with patient outcome and tumor progression in lung cancer","volume":"61","author":"Zhang","year":"2022","journal-title":"Ann Diagn Pathol"},{"issue":"6","key":"2026051819573223100_dgaf668-B37","doi-asserted-by":"crossref","first-page":"e177545","DOI":"10.1172\/jci.insight.177545","article-title":"Inhibition of histone methyltransferase EZH2 for immune interception of colorectal cancer in lynch syndrome","volume":"10","author":"Bowen","year":"2025","journal-title":"JCI Insight"},{"issue":"3","key":"2026051819573223100_dgaf668-B38","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12079-021-00655-x","article-title":"Expression and associated epigenetic mechanisms of the Ca(2+)-signaling genes in breast cancer subtypes and epithelial-to-mesenchymal transition","volume":"16","author":"Hern\u00e1ndez-Oliveras","year":"2022","journal-title":"J Cell Commun Signal"},{"issue":"1","key":"2026051819573223100_dgaf668-B39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13045-024-01524-x","article-title":"cAMP-PKA\/EPAC signaling and cancer: the interplay in tumor microenvironment","volume":"17","author":"Zhang","year":"2024","journal-title":"J Hematol Oncol"},{"issue":"2","key":"2026051819573223100_dgaf668-B40","first-page":"152","article-title":"Genome-wide ChIP-seq analysis of EZH2-mediated H3K27me3 target gene profile highlights differences between low- and high-grade astrocytic tumors","volume":"38","author":"Sharma","year":"2017","journal-title":"Carcinogenesis"},{"key":"2026051819573223100_dgaf668-B41","doi-asserted-by":"crossref","first-page":"1181764","DOI":"10.3389\/fcell.2023.1181764","article-title":"H3 histone methylation landscape in male urogenital cancers: from molecular mechanisms to epigenetic biomarkers and therapeutic targets","volume":"11","author":"Burlibasa","year":"2023","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"2026051819573223100_dgaf668-B42","first-page":"2125","article-title":"H3k4me3 and Wdr82 are associated with tumor progression and a favorable prognosis in human colorectal cancer","volume":"16","author":"Liu","year":"2018","journal-title":"Oncol Lett"},{"issue":"1-2","key":"2026051819573223100_dgaf668-B43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2009.08.020","article-title":"Regulation of vitamin D receptor function in MEN1-related parathyroid adenomas","volume":"313","author":"Dreijerink","year":"2009","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"2026051819573223100_dgaf668-B44","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s40618-019-01098-3","article-title":"Dysregulated mitogen-activated protein kinase pathway mediated cell cycle disruption in sporadic parathyroid tumors","volume":"43","author":"Arya","year":"2020","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2026051819573223100_dgaf668-B45","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3803\/EnM.2023.1827","article-title":"Protein signatures of parathyroid adenoma according to tumor volume and functionality","volume":"39","author":"Kong","year":"2024","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"1","key":"2026051819573223100_dgaf668-B46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13148-021-01187-2","article-title":"H3k36 trimethylation-mediated biological functions in cancer","volume":"13","author":"Xiao","year":"2021","journal-title":"Clin Epigenetics"},{"issue":"1","key":"2026051819573223100_dgaf668-B47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13072-022-00446-7","article-title":"Structural and functional specificity of H3K36 methylation","volume":"15","author":"Lam","year":"2022","journal-title":"Epigenetics Chromatin"},{"issue":"1","key":"2026051819573223100_dgaf668-B48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.52601\/bpr.2021.200042","article-title":"Study on the spatial distribution patterns of histone modifications in hippo pathway genes","volume":"7","author":"Su","year":"2021","journal-title":"Biophys Rep"},{"issue":"2","key":"2026051819573223100_dgaf668-B49","doi-asserted-by":"crossref","first-page":"e2202937","DOI":"10.1002\/advs.202202937","article-title":"Tumor cell-intrinsic SETD2 deficiency reprograms neutrophils to foster immune Escape in pancreatic tumorigenesis","volume":"10","author":"Niu","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"2026051819573223100_dgaf668-B50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.molcel.2017.03.006","article-title":"Delayed accumulation of H3K27me3 on nascent DNA is essential for recruitment of transcription factors at early stages of stem cell differentiation","volume":"66","author":"Petruk","year":"2017","journal-title":"Mol Cell"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf668\/65885361\/dgaf668.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/6\/1680\/65885361\/dgaf668.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/6\/1680\/65885361\/dgaf668.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:57:45Z","timestamp":1779148665000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/6\/1680\/8380276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12,15]]},"published-print":{"date-parts":[[2026,5,19]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf668","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2025,12,15]]}}}